Fractionated Radiosurgery Reduced Brain Metastasis Recurrence
A new clinical trial shows dividing radiation doses over multiple sessions improves survival for brain metastasis patients.
Updated on Sept. 28, 2026 in Stroke
Live Poll
Do you trust that new cancer treatment options are effectively improving long-term quality of life?
Fractionated radiosurgery has demonstrated superior results in reducing the recurrence of brain metastases compared to single-session radiation. The findings suggest that spreading treatment over several sessions leads to higher overall survival rates.
Why it matters
By dividing radiation therapy into three to five doses, healthy brain tissue has more time to recover between treatments. This approach offers a more effective strategy for managing brain metastases than traditional single-dose stereotactic radiosurgery.
The Alliance A071801 trial randomized 242 patients with median surgical cavity volumes of 16.5 cm3 and 14.8 cm3 respectively. Grade 1+ radiation necrosis occurred at rates of 14% and 10%, while cerebral edema rates were 8% and 9%.
The players
ASTRO
The American Society for Radiation Oncology is a professional organization representing radiation oncologists and medical professionals.
The details
The study compared fractionated stereotactic radiosurgery, which delivers therapy over three to five sessions, to conventional single-session stereotactic radiosurgery. The data indicates that fractionated treatment protocols significantly improve overall survival outcomes for patients.
Timeline
Patient treatments for the trial occurred between 2019 and 2022.
Results were presented at the ASTRO annual meeting on September 28, 2026.
The Big Picture
This research follows the parameters established by the Alliance A071801 clinical trial to evaluate brain metastasis management. It marks a departure from traditional single-session radiation, shifting the paradigm toward multi-session therapy as a standard for improving survival.
Patients may see shifts in standard treatment plans as medical providers incorporate multi-session radiosurgery to improve survival outcomes. Consult with a radiation oncologist to discuss whether fractionated therapy protocols align with specific recovery and health needs.
The takeaway
Fractionated radiosurgery provides a meaningful survival benefit for patients by balancing radiation efficacy with healthy tissue recovery. Patients should discuss the clinical advantages of multiple-session therapy compared to single-session options with their care team.
Further reading
Learn more about the latest developments in neuro-oncology and treatment protocols on our Stroke page.
Live Poll
Do you trust that new cancer treatment options are effectively improving long-term quality of life?
